[Conservative management of benign prostatic hyperplasia: are urologists satisfied?]
The author presents his point of view on the conservative management of benign prostatic hyperplasia and the role of combination therapy (co-administration of -blockers and 5-reductase inhibitors) in the treatment of voiding symptoms. The latest evidence for combination therapy of prostatic hyperplasia published in 2017 is also presented.